IbrutinibPneumonia, rash and lack of efficacy: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1905卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14632-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[21] AntineoplasticsAcneiform rash, acquired drug resistance and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1906 (1) : 58 - 58
[22] AntineoplasticsDiarrhoea and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1952 (1) : 67 - 67
[23] CemiplimabMyocarditis and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1977 (1) : 94 - 94
[24] RituximabDeath and lack of efficacy: 3 case reports
Reactions Weekly, 2025, 2042 (1) : 429 - 429
[25] UrokinaseHaematuria and lack of efficacy: 3 case reports
Reactions Weekly, 2021, 1871 (1) : 395 - 395
[26] AntineoplasticsHypercalcaemia and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1950 (1) : 44 - 44
[27] ChlormethineDermatitis and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 140 - 140
[28] DurvalumabPneumonitis and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1897 (1) : 160 - 160
[29] MethotrexateNeutropenia and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1932 (1) : 379 - 379
[30] AntineoplasticsGastroenteritis and lack of efficacy: 3 case reports
Reactions Weekly, 2023, 1961 (1) : 47 - 47

← 1 2 3 4 5 →